Circulating levels of hFABP have a prognostic value regarding the future deterioration of congestive heart failure in patients with dilated cardiomyopathy [16,33], and persistently increased serum concentrations of hFABP predict adverse clinical outcomes in patients with SHF [16]. The gene discussed is FABP3; the disease is dilated cardiomyopathy.